Clinician-Guided Weight Loss Program Pricing
Wellness Program
with Semaglutide
Starter Plan
$149 per month
$399 - 3 months ($133/mo equivalent)
$699 - 6 months ($116/mo equivalent)
Starter Plan is a 6 month plan for new clients
$199 per month
$498 - 3 months ($166/mo equivalent)
$984 - 6 months ($149/mo equivalent)
$1,500 - 12 months ($125/mo equivalent)
Ongoing Plan includes clients on medication already more than 6 months
Ongoing Plan
Consultation with an independent licensed clinician required
before starting a program with GLP-1 medications.
Wellness Program
with Tirzepatide
Starter Plan
$249 per month
$699 - 3 months ($233/mo equivalent)
$1,299 - 6 months ($216/mo equivalent)
Starter Plan is a 6 month plan for new clients
Ongoing Plan
$299 per month
$798 - 3 months ($266/mo equivalent)
$1,398 - 6 months ($233/mo equivalent)
$2,688 - 12 months ($224/mo equivalent)
Ongoing Plan includes clients on medication already more than 6 months
A $20 clinician consultation is required
at the time of the independent clinician visit.
All Programs Include
Wellness Plan
Community Support Group
Nutrition Coaching
Meal Planning Support
Fitness App
Fitness Coaching
Accountability
Weekly Support Calls
SimpleCare (Simple Life, LLC) does not practice medicine or sell prescription medication. Simple Care is a technology platform and referral partner offering access to a licensed physician network.The information provided on this website is for informational purposes only and is not intended as medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition. SimpleCare provides access to a network of licensed healthcare professionals who provide telehealth consultations and medical evaluations. Healthcare services are provided by independent licensed clinicians who exercise their own clinical judgment in evaluating and treating patients. Prescription medications are provided only when deemed medically appropriate by a licensed healthcare provider following a clinical evaluation. Not all patients will qualify for treatment. Individual results may vary. Weight loss results depend on many factors including lifestyle, medical history, adherence to treatment, and other health conditions. All medications carry potential risks and side effects. Patients should discuss potential risks, benefits, and alternatives with their healthcare provider prior to beginning treatment. This website and its services are not intended for medical emergencies. If you are experiencing a medical emergency, call 911 or seek immediate medical attention. The products and statements discussed on this website—excluding prescription medications when true—have not been evaluated by the U.S. Food and Drug Administration (FDA).
Semaglutide, tirzepatide, and other GLP-1 receptor agonist medications may not be approved by the FDA for all uses discussed.
Important Notes:
-
*Compounded semaglutide is not FDA-approved and the FDA does not evaluate compounded products for safety, effectiveness, or quality. Ozempic® and Wegovy® are not compounded. Ozempic® and Wegovy® are both products and registered trademarks or Novo Nordisk A/S. Ozempic® is FDA-approved for type 2 diabetes but may be prescribed off-label for weight loss per a healthcare practitioner's discretion. Wegovy® has been approved by the FDA for diabetes and weight loss.
-
*Compounded tirzepatide is not FDA-approved and the FDA does not evaluate compounded products for safety, efficacy or quality. Mounjaro® is FDA-approved for type 2 diabetes and may be prescribed off-label for weight loss per a healthcare practitioner's discretion. Mounjaro® is a product and registered trademark of Eli Lily and Company.